Evidence map›Paper›PMID 36387771›Full record

ReviewJID innovations : skin science from molecules to population health2022

New Insights into Melanoma Tumor Syndromes.

Sarem Rashid, Sameer Gupta, Shelley R McCormick, Hensin Tsao

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JID innovations : skin science from molecules to population health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  4. High frequency of melanoma inTheranostics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Sarem RashidWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Sameer GuptaDepartment of Dermatology, The Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Shelley R McCormickMass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hensin TsaoWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Boston University · USBrown University · USHarvard University · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma tumor syndromes (MTS) represent an important minority of familial melanoma cases. In these patients, the accumulation of sequence alterations in essential genes may prelude the risk of internal malignancies, in addition to melanoma. Although several host and environmental factors have been implicated in familial melanoma, the exact mechanisms of cancer predisposition-particularly in the context of mixed cancer syndromes-still remain unclear. In this paper, we review new insights into MTS and elucidate recent efforts that guide individualized prognostication and treatment for these diseases in the past quarter century.

Indexed as

CI, confidence intervalCS, Cowden syndromeE2F, E2 factorFAMMM, familial atypical (multiple) mole melanomaLFS, Li‒Fraumeni syndromeLOF, loss-of-functionMTS, melanoma tumor syndromeNGS, next-generation sequencingPC, pancreatic cancerPHTS, PTEN hamartoma tumor syndromessDNA, single-strand DNATERT, telomerase reverse transcriptaseTPDS, tumor predisposition syndromeUM, uveal melanoma

Identifiers

PMID36387771
PMCPMC9641259
OpenAlexW4294192417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.